Dr. Luxia Zhang is the Deputy Dean of the National Institute of Health Data Science at Peking University, China, and Professor in the Renal Division of Peking University First Hospital, China. She obtained her MD degree at Peking University and her MPH degree at Harvard School of Public Health. Her research focuses on prevalence, risk factors, intervention, and management of kidney disease in China. Most of her work provides first-hand information on kidney disease in China and has gained wide attention internationally. During the last several years, her study interests have been expanded to the management of major non-communicable chronic diseases by leveraging the power of big data and artificial intelligence. Her studies have been published in top medical journals including N Engl J Med, the Lancet and Br Med J. Dr. Zhang was named on the list of the "World's Top 2% Scientists 2020-2022" from Stanford University and the "China Highly Cited Scholars" list in 2020-2022 from Elsevier. She is the Vice President of Health Data Application and Management Committee, Chinese Hospital Association; Deputy Editor of Health Data Science (a Science Partner Journal); member of the Lancet Digital Health International Advisory Board; and member of Editorial Boards of Clin J Am Soc Nephrol and Am J Kidney Dis.